June 25, 2026 at 05:06 AM 2 min readmarketsevergreen
Advit Jewels IPO Demand Surges as SME Market Sees Mixed Performance
Subscription Divergence:
The Indian primary market for new public offerings is experiencing a period of selective investor interest as of late June 2026. Advit Jewels has emerged as a high-demand standout, with the issue subscribed 44.16 times by the close of Day 2. Retail interest in the offering was particularly robust at 66.02 times, while the Qualified Institutional Buyer (QIB) segment recorded 15.11 times subscription, and Non-Institutional Investors reached 66.86 times. The Grey Market Premium (GMP) for the stock is currently estimated at ₹35, signaling a potential listing price near ₹115.
Contrasting SME Outcomes:
Market participants are navigating a complex landscape where SME offerings see significantly different results. While Avience Biomedicals made a stellar debut on the NSE SME exchange on June 25, 2026, listing at a 90% premium over its issue price of ₹208, other firms have struggled. CSM Technologies saw a tepid debut with only 0.26 times subscription on Day 1, indicating potential for a flat listing. Similarly, Waterways Leisure Tourism has faced a modest reception, recording only 1.13 times subscription by Day 2, with the QIB portion remaining notably quiet at 0.05 times.
Investor Outlook:
The current trend highlights that investors are increasingly scrutinizing valuations, financial health, and order books before committing capital. Beyond individual IPOs, investors are also positioning for future high-profile technology sector entries by channeling capital into related ETFs like AGIX in anticipation of rumors surrounding firms like Anthropic. This selective behavior indicates that while strong demand exists for niche, retail-focused SMEs, mainboard and IT-service offerings are being handled with much greater caution as the listing calendar remains busy throughout the quarter.
Pulse Intelligence
AI AnalysisContext & Background
- Indian primary markets are showing high retail participation, often leading to wide discrepancies in subscription rates across various industries.
- Grey Market Premium (GMP) remains a key, albeit unofficial, metric used by retail investors to gauge potential listing-day performance.
- The NSE and BSE SME exchanges have seen record activity in 2026 as firms seek growth capital, leading to a highly saturated IPO calendar.
Key Consequences
- The success of firms like Avience Biomedicals is expected to encourage further SME listings in the coming months, provided financials remain robust.
- Tepid interest in offerings like CSM Technologies may lead to more conservative pricing strategies by issuers in future IPO filings.
- Investors are likely to increasingly rely on historical GMP trends and institutional subscription data to manage risk in volatile IPO debut cycles.
Market & Economic Impact
Strong retail demand in select IPOs contrasts with institutional caution, indicating a highly selective market phase for new listings.

